跳至主要内容
临床试验/NCT02941120
NCT02941120已完成不适用

Retrospective Observational Study for Reconstruction of Localized, Full-thickness Cartilage Defects in the Knee Joint With In-situ Polymerizable and Chondrocyte Populated Biomaterial (NOVOCART® Inject)

Tetec AG7 个研究点 分布在 1 个国家目标入组 245 人开始时间: 2015年12月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
Tetec AG
入组人数
245
试验地点
7
主要终点
Number of adverse drug reaction/serious adverse drug reaction

研究概览

简要总结

Retrospective non-interventional study to evaluate safety and efficacy of NOVOCART® Inject in patients with full-thickness cartilage defects in the knee joint.

详细描述

Retrospective and multicenter non-interventional study to evaluate safety and efficacy of NOVOCART® Inject in patients with localized full-thickness cartilage defects in the knee joint.

Safety: Measuring the number of adverse drug reactions/serious adverse drug reactions since treatment and up to the present time.

Efficacy: Evaluate symptoms and functional status at the present time using IKDC 2000 (International Knee Documentation Committee) and KOOS (Knee injury osteoarthritis outcome score).

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Retrospective

入排标准

年龄范围
14 Years 至 50 Years(Child, Adult)
性别
All
接受健康志愿者

入选标准

  • male and female patients
  • juvenile patients with closed epiphysial plate
  • insulated full-thickness cartilage damage of the knee Joint, ICRS (International Cartilage Repair Society) grade 3-4
  • defect size ≥ 2.5 and ≤ 10 cm2
  • intact or reconstructed bony subchondral plate
  • in the case of deep bony substance defects, additional bony reconstruction is needed

排除标准

  • radiographic signs of osteoarthritis of Kellgren and Lawrence > 2
  • joint stiffness
  • arthrofibrosis
  • malalignment in the knee (valgus- or varus deformity) > 3° (correction contemporary to the ACT)
  • insufficient reconstructed ligaments (correction contemporary to the ACT)
  • defective position patella (correction contemporary to the ACT)
  • sled prosthesis implants or carbon pin
  • inflammatory joint diseases (f.e. rheumatoid arthritis)
  • corresponding cartilage defects ("kissing lesions")
  • more than two independent cartilage defects in one knee
  • primary cartilage reconstructive treatment in children and juvenile with open epiphysial plate
  • diffuse chondromalacia
  • congenital or gained deformity of patella

结局指标

主要结局

Number of adverse drug reaction/serious adverse drug reaction

时间窗: Up to 24 months

Number of adverse drug reaction/serious adverse drug reaction as a measurement of safety

次要结局

  • Outcome of IKDC 2000(Up to 24 months)
  • Outcome of KOOS(Up to 24 months)

研究者

发起方
Tetec AG
申办方类型
Industry
责任方
Sponsor

研究点 (7)

Loading locations...

相似试验